Neovasc Inc. Cash per Share

Cash per Share of NVCN for past 10 years: annual, quarterly and twelve month trailing (TTM) including Cash per Share growth rates and interactive chart.


Highlights and Quick Summary

  • Cash per Share for the quarter ending March 31, 2022 was 16.29 (a -19.95% decrease compared to previous quarter)
  • Year-over-year quarterly Cash per Share decreased by -30.4%
  • Annual Cash per Share for 2021 was 20.35 (a 4.55% increase from previous year)
  • Annual Cash per Share for 2020 was 19.46 (a -3.96% decrease from previous year)
  • Annual Cash per Share for 2019 was 20.27 (a -87.64% decrease from previous year)
Visit stockrow.com/NVCN for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Cash per Share of Neovasc Inc.

Most recent Cash per Shareof NVCN including historical data for past 10 years.

Interactive Chart of Cash per Share of Neovasc Inc.

Neovasc Inc. Cash per Share for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 16.29
2021 20.35 20.6 23.41 35.93 20.35
2020 19.46 17.59 23.42 16.12 19.46
2019 20.32 37.99 67.25 75.35 20.27
2018 163.3 192.14 373.95 21.17 164.0
2017 5305.21 23934.25 25553.47 27833.13 5317.72
2016 34427.63 0.0 13436.22 17371.56 34427.63
2015 20380.07 23844.44 28240.74 32768.0 21163.92
2014 7059.09 9072.73 10700.0 13000.0 7398.86
2013 1736.84 2110.53 2810.53 2677.78 1736.84
2012 3084.21 1127.78 1438.89 1766.67 3255.56
2011 2294.12 2294.12

Business Profile of Neovasc Inc.

Sector: Healthcare
Industry: Medical Devices
Neovasc Inc., a specialty medical device company, develops, manufactures, and markets products for cardiovascular marketplace in Europe and internationally. Its products include the Tiara technology for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina. The company was formerly known as Medical Ventures Corp. and changed its name to Neovasc Inc. in July 2008. Neovasc Inc. was incorporated in 2000 and is headquartered in Richmond, Canada.